NICE recommends VAZKEPA® (icosapent ethyl) to reduce cardiovascular risk
Icosapent ethyl has been recommended by NICE for use across the NHS in England and Wales to reduce cardiovascular (CV) risk in adult statin-treated...
Defence Therapeutics provides an update on its numerous anti-cancer projects
Biotechnology pioneers Defence Therapeutics outline its current research and development progress in a plethora of anti-cancer endeavours.
In Q1 of 2022, Defence signed an agreement...
B Medical Systems receives WHO prequalification for their U201 Ultra-low freezer
B Medical Systems, a global leader in medical cold chain solutions, has announced that the company’s Ultra-Low Freezer U201 has received the world’s first...
Defence Therapeutics move closer to AccuTOXTM Phase I clinical trial
Defence Therapeutics has established an agreement with CATO SMS, who will advise on submitting the company’s clinical application to Health Canada to initiate a...
Defence Therapeutics’ HPV vaccine achieves a higher humoral response than Gardasil-9
Canadian biotechnology company Defence Therapeutics has revealed that its novel HPV vaccine has demonstrated a higher humoral response than the Gardasil-9 vaccine.
The company’s new...
B Medical Systems launches its manufacturing facility in Mundra, Gujarat
B Medical Systems, a global leader in medical cold chain solutions, headquartered in Luxembourg, has inaugurated its new Indian manufacturing facility in Mundra, Gujarat...
Defence Therapeutics achieves major milestone with anti-cancer molecule
Biotechnology company Defence Therapeutics has announced the start of its final step in GLP studies on its anti-cancer AccuTOXTM molecule at Eurofins Advinus Limited...
B Medical Systems announces Andrea Scammacca as Chief Operating Officer
B Medical Systems, a global leader in medical cold chain products, has announced the appointment of Andrea Scammacca as its new Chief Operating Officer....
AccumTM platform greatly enhances CRISPR gene-editing technology
Defence Therapeutics has announced that its AccumTM platform can potently enhance Cas9 delivery in target cells, significantly advancing CRISPR gene-editing technology.
The CRISPR technology offers...
B Medical systems announce Marnick Dewilde as Chief Sales Officer
B Medical Systems, a global leader in medical cold chain products, has announced the appointment of Marnick Dewilde as the Chief Sales Officer for...
XPhyto Therapeutics: rapid PCR test for COVID-19 in development
XPhyto Therapeutics Corp. is a German-Canadian biotech company focused on next-generation drug formulations, diagnostics and novel pharmaceutical agents. The company is currently developing its...
Defence Therapeutics: changing the face of vaccines using AccumTM technology
Biotechnology specialists Defence Therapeutics are changing the face of vaccines using its AccumTM technology to enable precise delivery of proteins of pharmacological interest to...
Defence Therapeutics announces exciting addition to its board of directors
Biotechnology specialists Defence Therapeutics has revealed today that Dr Riam Shammaa has been appointed to its board of directors.
Dr Riam Shammaa, MD, is a...
Defence Therapeutics successfully test new COVID vaccine
Defence Therapeutics has sensationally revealed that they have successfully completed studies of their new COVID vaccine in a non-rodent rabbit model.
The innovative new COVID...
Maintaining an active and healthy lifestyle as we age in a digital world
Maintaining optimal physical condition becomes increasingly paramount as we age; to better understand how to achieve an active and healthy lifestyle, Aquarate discusses with...
AccumTM variants successfully increase breast cancer treatment potency
Biotechnology experts Defence Therapeutics have revealed strong in vitro results of its AccumTM variants on the ADC breast cancer treatment called Enhertu® (fam-trastuzumab-deruxtecan-nxki), which...
Defence Therapeutics prepares to test its DC cancer vaccine against melanoma
Defence Therapeutics is finalising all required steps in preparation for a pre-IND meeting to initiate a phase I trial against melanoma using its DC cancer...
Vaccine cold chain pioneers inaugurate new factory extension
Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters.
The factory extension...
Defence Therapeutics embark on next stage of breast cancer treatment development
In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
Defence Therapeutics’ new COVID vaccine achieves successful testing
Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model.
The new COVID vaccine – called...
